1. Based on 2019 recommendations from the American Diabetes Association, SGLT-2 inhibitors would be most appropriate to use:

2. Based on American Diabetes Association recommendations, GLP-1 receptor agonists are given preference in patients with:

3. Which GLP-1 receptor agonist has the strongest evidence for use in patients with cardiovascular disease?

4. GLP-1 receptor agonists should be avoided in patients with:

5. Potential side effects with SGLT-2 inhibitors include all of the following EXCEPT:

Evaluation Questions

6. To what extent did the program meet objective #1?

7. To what extent did the program meet objective #2?

8. Rate the effectiveness of how well the program related to your educational needs:

9. Rate how well the active learning strategies (questions, cases, discussions) were appropriate and effective learning tools:

10. Rate the quality of the faculty:

11. Rate the effectiveness and the overall usefulness of the material presented:

12. Rate the appropriateness of the examination for this activity:

13. Rate the effectiveness of how well the activity related to your practice needs:

14. Rate the effectiveness of how well the activity will help you improve patient care:

15. Will the information presented cause you to change your practice?

16. Are you committed to making these changes?

17. As a result of this activity, did you learn something new?

18. What is your practice setting or area of practice?

19. How many years have you been in practice?

« Return to Activity